Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has issued an update.
Consun Pharmaceutical Group Ltd. has announced the composition of its board of directors and the roles of each member. The board includes executive, non-executive, and independent non-executive directors, and has established four committees: Audit, Remuneration, Nomination, and Environmental, Social and Governance. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic direction and stakeholder engagement.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$22.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It is primarily focused on the production and distribution of pharmaceutical products.
Average Trading Volume: 3,493,973
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.81B
For detailed information about 1681 stock, go to TipRanks’ Stock Analysis page.